INDOCO NSE filing

Indoco Remedies to Hold 79th AGM on Sep 17, 2026, for E-voting

The RealCase readLow impact Neutral

Indoco Remedies Limited will hold its 79th AGM on September 17, 2026, via VC/OAVM. Remote e-voting is open from September 10 to September 16, 2026. The Annual Report for FY2025-26 was dispatched on August 21, 2026.

Why it matters

This is a standard corporate compliance announcement regarding an upcoming AGM and does not contain any new material business or financial information that would significantly impact the company's stock or operations.

The market read

The announcement is a routine procedural update regarding the Annual General Meeting and e-voting, with no new financial or business developments.

Indoco Remedies Limited has announced the details for its 79th Annual General Meeting (AGM), scheduled to be held on Thursday, September 17, 2026, at 10:30 a.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with current regulations.

The company has sent the Annual Report for the financial year 2025-2026 along with the Notice of AGM to its members on August 21, 2026. The Annual Report and AGM Notice are also available on the company's website (www.indoco.com) and the websites of the BSE and NSE.

Indoco Remedies is providing a remote e-voting facility for its members, which commenced on September 10, 2026, and will conclude on September 16, 2026, at 05:00 p.m. IST. Members who have not registered their email addresses can follow specific procedures to update their details and participate. Queries regarding e-voting and attending the AGM can be addressed to the company's Registrar and Transfer Agent, MUFG Intime India Private Limited.

Filing to action

What to do with a filing like this

Indoco Remedies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Indoco Remedies Limited. Read the original for the full detail.

View original filing